Entheon Biomedical (XCNQ:ENBI) Beginning Cash Position : C$0.35 Mil (As of Feb. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Entheon Biomedical Beginning Cash Position?

Entheon Biomedical's Beginning Cash Position for the quarter that ended in Feb. 2024 was C$0.35 Mil.

Entheon Biomedical's quarterly Beginning Cash Position declined from Aug. 2023 (C$0.49 Mil) to Nov. 2023 (C$0.39 Mil) and declined from Nov. 2023 (C$0.39 Mil) to Feb. 2024 (C$0.35 Mil).

Entheon Biomedical's annual Beginning Cash Position declined from Nov. 2021 (C$2.79 Mil) to Nov. 2022 (C$2.05 Mil) and declined from Nov. 2022 (C$2.05 Mil) to Nov. 2023 (C$0.68 Mil).

Entheon Biomedical Beginning Cash Position Historical Data

The historical data trend for Entheon Biomedical's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Entheon Biomedical Beginning Cash Position Chart

Entheon Biomedical Annual Data

Trend

Mar17

Mar18

Mar19

Mar20

Nov21

Nov22

Nov23

Beginning Cash Position

Get a 7-Day Free Trial

0.34

1.22

2.79

2.05

0.68

Entheon Biomedical Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24
Beginning Cash Position	Get a 7-Day Free Trial															0.68	0.49	0.49	0.39	0.35

Entheon Biomedical Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

Entheon Biomedical Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of Entheon Biomedical's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Entheon Biomedical (XCNQ:ENBI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Entheon Biomedical Corp (XCNQ:ENBI) » Definitions » Beginning Cash Position

Comparable Companies

Traded in Other Exchanges

ENTBF:USA 1XU1:Germany

Address

999 West Broadway Street, Suite 720, Vancouver, BC, CAN, V5Z 1K5

Website

https://www.entheonbiomedical.com

Entheon Biomedical Corp is a biotechnology research and development company committed to developing and commercializing a portfolio of safe and effective Dimethyltryptamine based psychedelic therapeutic products (DMT Products) for the purposes of treating addiction and substance use disorders. Entheon intends to generate revenue through the sale of its DMT Products to physicians, clinics, and licensed psychiatrists in the United States, certain countries in the European Union, and throughout Canada.

Executives

Brian Jahns

Senior Officer

Entheon Biomedical (XCNQ:ENBI) Headlines

No Headlines